CHA News Article

Pfizer Reports Shortage of Key Injectable Medications

Recently, member hospitals have notified CHA of shortages of key emergency medications, particularly injectable drugs manufactured by Pfizer. Pfizer has issued the attached letter updating providers on the shortages as well as the steps the company is taking to meet demand expeditiously, including:

  • Prioritizing the manufacture and delivery of medically necessary drugs
  • Allocating certain medicines to minimize stock outs
  • Increasing production at key injectable manufacturing plants
  • Adding resources to address distribution delays
  • Increasing inventory levels for key manufacturing materials

CHA will continue to monitor the situation and encourages members to direct questions to BJ Bartleson, vice president, nursing and clinical services, at or (916) 552-7537. Providers should note that, overall, drug shortages have decreased in recent years; for more information, visit the American Society of Health-System Pharmacists website.